Organization: Health Canada
Year: 2022
Month: February
Request Number: A-2019-001781
Request Summary: All correspondence between Health Canada and the sponsor relating to any abbreviated new drug submission (ANDS) filed for a leuprolide acetate product, namely, any ANDS filed for the drug ZEULIDE, whether the ANDS was approved or not.
Disposition: Disclosed in part
Number of pages: 132